Literature DB >> 7786660

Ventilatory responses to exercise in adults after repair of tetralogy of Fallot.

A L Clark1, M A Gatzoulis, A N Redington.   

Abstract

BACKGROUND: Adult patients with total correction of tetralogy of Fallot may have poor exercise capacity associated with impaired right heart function and in particular pulmonary regurgitation. The ventilatory responses to exercise were studied in a group of such patients to assess relations between ventilation, exercise capacity, and right ventricular function.
METHODS: 30 patients (7 female) (aged 27.8 (6.0) years) and 30 (7 female) controls of a similar age range were studied prospectively. All underwent exercise testing with metabolic gas exchange to determine peak oxygen consumption (peak VO2), and (as indices of the ventilatory response) the slope of the relation between both respiratory rate (RR) and ventilation (VE) against carbon dioxide production (VCO2). Patients were studied with pulsed wave Doppler echocardiography to determine pulmonary arterial systolic and diastolic flow characteristics. Patients were defined as having restrictive right ventricular function where diastolic pulmonary forward flow was seen coincident with atrial systole.
RESULTS: In the group with tetralogy of Fallot mean (SD) peak VO2 was 35.3 (7.5) ml/kg/min (93.6 (15.3) % of expected for age, weight, height and sex). The RR/VCO2 slope was steeper in the Fallot group (6.8 (2.6) v 9.6 (4.7), P < 0.02). Those with restrictive right ventricles achieved a higher peak VO2 than those without (82.5 (10.1) % v 100.9 (13.8), P < 0.001). In the Fallot group alone, there was an inverse relation between ventilatory response and peak VO2 (RR/VCO2 v peak VO2; r = -0.63, P = 0.003: VE/VCO2 v peak VO2; r = -0.62, P < 0.001).
CONCLUSIONS: Many of these patients with repaired tetralogy of Fallot had near normal exercise capacity, but as exercise capacity decreased, the ventilatory response to exercise increased. This was not due to alterations in pulmonary function tests or to the effects of cardiac size causing decreased lung volume. It may be that the increased ventilatory rate at a given level of carbon dioxide production acts as a respiratory pump aiding right ventricular function.

Entities:  

Mesh:

Year:  1995        PMID: 7786660      PMCID: PMC483861          DOI: 10.1136/hrt.73.5.445

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  A new technique for the assessment of pulmonary regurgitation and its application to the assessment of right ventricular function before and after repair of tetralogy of Fallot.

Authors:  A N Redington; P J Oldershaw; E A Shinebourne; M L Rigby
Journal:  Br Heart J       Date:  1988-07

2.  The measurement of metabolic gas exchange and minute volume by mass spectrometry alone.

Authors:  N J Davies; D M Denison
Journal:  Respir Physiol       Date:  1979-02

3.  Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure.

Authors:  B J Baker; M M Wilen; C M Boyd; H Dinh; J A Franciosa
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778

4.  Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure.

Authors:  N P Buller; P A Poole-Wilson
Journal:  Br Heart J       Date:  1990-05

5.  Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation.

Authors:  J S Carvalho; E A Shinebourne; C Busst; M L Rigby; A N Redington
Journal:  Br Heart J       Date:  1992-06

6.  A critical threshold of exercise capacity in the ventilatory response to exercise in heart failure.

Authors:  S W Davies; T M Emery; M I Watling; G Wannamethee; D P Lipkin
Journal:  Br Heart J       Date:  1991-04

7.  Respiratory gas exchange in the assessment of patients with impaired ventricular function.

Authors:  D P Lipkin; J Perrins; P A Poole-Wilson
Journal:  Br Heart J       Date:  1985-09

8.  Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

Authors:  J A Franciosa; M Park; T B Levine
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

9.  Left ventricular function after repair of tetralogy of fallot and its relationship to age at surgery.

Authors:  K M Borow; L H Green; A R Castaneda; J F Keane
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690

10.  Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure.

Authors:  L I Fink; J R Wilson; N Ferraro
Journal:  Am J Cardiol       Date:  1986-02-01       Impact factor: 2.778

View more
  5 in total

Review 1.  Maximising the clinical use of exercise gaseous exchange testing in children with repaired cyanotic congenital heart defects: the development of an appropriate test strategy.

Authors:  A McManus; M Leung
Journal:  Sports Med       Date:  2000-04       Impact factor: 11.136

2.  Oxygen uptake versus exercise intensity: a new concept in assessing cardiovascular exercise function in patients with congenital heart disease.

Authors:  T Reybrouck; L Mertens; S Brusselle; M Weymans; B Eyskens; J Defoor; M Gewillig
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

3.  Longitudinal exercise capacity of patients with repaired tetralogy of fallot.

Authors:  Alaina K Kipps; Dionne A Graham; David M Harrild; Erik Lewis; Andrew J Powell; Jonathan Rhodes
Journal:  Am J Cardiol       Date:  2011-04-29       Impact factor: 2.778

4.  Serial cardiopulmonary exercise testing in patients with previous Fontan surgery.

Authors:  Susan M Fernandes; Doff B McElhinney; Paul Khairy; Dionne A Graham; Michael J Landzberg; Jonathan Rhodes
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

Review 5.  End-Diastolic Forward Flow and Restrictive Physiology in Repaired Tetralogy of Fallot: A Systematic Review and Meta-Analysis.

Authors:  Jef Van den Eynde; Emilie Derdeyn; Art Schuermans; Pushpa Shivaram; Werner Budts; David A Danford; Shelby Kutty
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.